GlassScriptPhysician profile
Steve P Lee
NPI 1558395244
$7,021.99
in general payments reported to CMS, 2019-2025
8 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,999 · 2020: $228 · 2022: $22.92 · 2023: $419 · 2024: $215 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $5,923.14 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $636.68 | 2023-2025 | Tecnis Iol, Tecnis Iol, Veritas Vision System |
| Brainlab, INC. | $227.82 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $90.17 | 2023 | Libtayo |
| Allergan, INC. | $75.90 | 2019 | |
| Siemens Medical Solutions USA, INC. | $29.41 | 2023 | Varian Cryocare Touch System |
| Myovant Sciences Gmbh | $22.92 | 2022 | |
| Boston Scientific Corporation | $15.95 | 2024 | Spaceoar Vue System - 10ml |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.